NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
12.12
-0.36 (-2.88%)
At close: Apr 28, 2026, 4:00 PM EDT
12.25
+0.13 (1.07%)
Pre-market: Apr 29, 2026, 8:44 AM EDT
NovoCure Employees
NovoCure had 1,605 employees as of December 31, 2025. The number of employees increased by 117 or 7.86% compared to the previous year.
Employees
1,605
Change (1Y)
117
Growth (1Y)
7.86%
Revenue / Employee
$408,320
Profits / Employee
-$84,877
Market Cap
1.40B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| AdaptHealth | 10,900 |
| Enovis | 7,802 |
| UFP Technologies | 4,846 |
| CONMED | 3,900 |
| Tandem Diabetes Care | 2,500 |
| Avanos Medical | 2,287 |
| Artivion | 1,800 |
| Inspire Medical Systems | 1,333 |
NVCR News
- 4 weeks ago - Novocure to Report First Quarter 2026 Financial Results - Business Wire
- 4 weeks ago - NovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic Cancer - Benzinga
- 4 weeks ago - Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer - Business Wire
- 7 weeks ago - NovoCure Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer - Business Wire
- 2 months ago - Novocure to Participate in 2026 Leerink Global Healthcare Conference - Business Wire
- 2 months ago - NovoCure Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update - Business Wire